Trial Profile
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Multiple Dose, Four Way Crossover Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Subjects at Therapeutic and Supratherapeutic Dose Levels
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Tramadol (Primary) ; Moxifloxacin
- Indications Pain
- Focus Adverse reactions
- Sponsors Janssen
- 24 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 25 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2015 Status changed from recruiting to active, no longer recruiting , as reported by ClinicalTrials.gov.